$498 Million is the total value of SABBY MANAGEMENT, LLC's 103 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 66.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | SECTOR HEALTHCAREput | $46,372,000 | -10.6% | 4,634 | -20.8% | 9.31% | -56.8% | |
| Sell | ISHARES RUSSELL 2000put | $27,219,000 | +15.6% | 1,901 | -7.6% | 5.46% | -44.2% | |
| Sell | SPDR S&P 500put | $18,810,000 | -51.3% | 610 | -59.3% | 3.78% | -76.5% | |
| Sell | SPDR GOLD TRUSTcall | $7,297,000 | -49.4% | 436 | -55.2% | 1.46% | -75.6% | |
| Sell | SECTOR HEALTHCAREcall | $6,665,000 | -24.8% | 666 | -33.4% | 1.34% | -63.7% | |
| Sell | AVEO PHARMACEUTICALS INCput | $3,763,000 | +56.1% | 7,307 | -28.7% | 0.76% | -24.7% | |
| Sell | SPDR GOLD TRUSTput | $3,598,000 | -82.6% | 215 | -84.6% | 0.72% | -91.6% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $1,715,000 | +26.8% | 40,500 | -17.3% | 0.34% | -38.8% |
| PAVMZ | Sell | PAVMED INC*w | $867,000 | -9.9% | 842,210 | -18.7% | 0.17% | -56.5% |
| Sell | AURINIA PHARMACEUTICALScall | $453,000 | +1.1% | 279 | -9.7% | 0.09% | -51.1% | |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $450,000 | +10.8% | 87,319 | -22.1% | 0.09% | -46.7% |
| AUPH | Sell | AURINIA PHARMACEUTICALS | $406,000 | -34.2% | 25,000 | -41.2% | 0.08% | -68.4% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS | $354,000 | -0.6% | 76,970 | -28.5% | 0.07% | -52.0% |
| Sell | ORAMED PHARMS INCput | $335,000 | -39.1% | 949 | -47.5% | 0.07% | -70.7% | |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $288,000 | -62.0% | 125,312 | -71.5% | 0.06% | -81.6% |
| PSTI | Sell | PLURISTEM THERAPEUTICS | $263,000 | -62.7% | 29,699 | -84.5% | 0.05% | -81.9% |
| BPTH | Sell | BIO PATH HLDGS INC | $227,000 | -67.3% | 45,000 | -70.8% | 0.05% | -84.0% |
| MDGSW | Sell | MEDIGUS LTD*w | $123,000 | +459.1% | 585,859 | -41.8% | 0.02% | +177.8% |
| SNCA | Sell | SENECA BIOPHARMA INC | $83,000 | +9.2% | 115,001 | -0.3% | 0.02% | -46.9% |
| ENLV | Sell | ENLIVEX THERAPEUTICS LTD | $65,000 | -96.9% | 12,925 | -97.1% | 0.01% | -98.5% |
| RWLK | Sell | REWALK ROBOTICS LTD | $34,000 | -65.7% | 19,082 | -91.7% | 0.01% | -82.9% |
| TEUM | Sell | PARETEUM CORP | $35,000 | -85.2% | 56,757 | -90.1% | 0.01% | -92.9% |
| Sell | PARETEUM CORPput | $12,000 | -42.9% | 190 | -66.8% | 0.00% | -77.8% | |
| CNBX | Exit | CANNABICS | $0 | – | -7,286 | -100.0% | 0.00% | – |
| Exit | INTEC PHARMA LTDcall | $0 | – | -175 | -100.0% | -0.00% | – | |
| SINT | Exit | SINTX TECHNOLOGIES INC | $0 | – | -18,272 | -100.0% | -0.00% | – |
| RBZHF | Exit | REEBONZ HOLDING LTD | $0 | – | -25,000 | -100.0% | -0.00% | – |
| Exit | TENAX THERAPEUTICS INC | $0 | – | -32,842 | -100.0% | -0.01% | – | |
| SYN | Exit | SYNTHETIC BIOLOGICS INC | $0 | – | -76,896 | -100.0% | -0.01% | – |
| Exit | ACELRX PHARMS INCput | $0 | – | -220 | -100.0% | -0.01% | – | |
| ADMP | Exit | ADAMIS PHARMACEUTICALS | $0 | – | -88,210 | -100.0% | -0.01% | – |
| SHIPZ | Exit | SEANERGY MARITIME*w | $0 | – | -897,499 | -100.0% | -0.02% | – |
| XBIO | Exit | XENETIC BIOSCIENCES INC | $0 | – | -60,523 | -100.0% | -0.02% | – |
| Exit | INVIVO THERAPEUTICS | $0 | – | -32,660 | -100.0% | -0.02% | – | |
| BLIN | Exit | BRIDGELINE DIGITAL INC | $0 | – | -110,000 | -100.0% | -0.03% | – |
| EARS | Exit | AURIS MEDICAL HOLDING | $0 | – | -89,451 | -100.0% | -0.03% | – |
| Exit | AMARIN CORP PLCcall | $0 | – | -188 | -100.0% | -0.03% | – | |
| BNTC | Exit | BENITEC BIOPHARMA LTDads | $0 | – | -21,592 | -100.0% | -0.04% | – |
| EFOI | Exit | ENERGY FOCUS INC | $0 | – | -267,298 | -100.0% | -0.04% | – |
| Exit | BELLICUM PHARMACEUTICALS | $0 | – | -18,927 | -100.0% | -0.04% | – | |
| NURO | Exit | NEUROMETRIX INC | $0 | – | -82,250 | -100.0% | -0.04% | – |
| Exit | GENPREX INCput | $0 | – | -441 | -100.0% | -0.04% | – | |
| Exit | APPLIED DNA SCIENCES INC | $0 | – | -26,397 | -100.0% | -0.04% | – | |
| ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -203,536 | -100.0% | -0.05% | – |
| Exit | AKERS BIOSCIENCES INC | $0 | – | -55,400 | -100.0% | -0.05% | – | |
| Exit | OBALON THERAPEUTICS INC | $0 | – | -172,389 | -100.0% | -0.05% | – | |
| HEPA | Exit | HEPION PHARMACEUTICALS | $0 | – | -72,575 | -100.0% | -0.05% | – |
| MYO | Exit | MYOMO INC | $0 | – | -51,588 | -100.0% | -0.08% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -367,613 | -100.0% | -0.09% | – | |
| HSDT | Exit | HELIUS MEDICAL | $0 | – | -746,316 | -100.0% | -0.10% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -508,000 | -100.0% | -0.10% | – |
| ASTC | Exit | ASTROTECH CORP NEW | $0 | – | -99,667 | -100.0% | -0.11% | – |
| COCP | Exit | COCRYSTAL PHARMA INC | $0 | – | -392,206 | -100.0% | -0.12% | – |
| PTE | Exit | POLARITYTE INC | $0 | – | -349,358 | -100.0% | -0.16% | – |
| PHIO | Exit | PHIO PHARMACEUTICALS | $0 | – | -255,194 | -100.0% | -0.19% | – |
| SRNE | Exit | SORRENTO THERAPEUTICS | $0 | – | -287,386 | -100.0% | -0.22% | – |
| AMRN | Exit | AMARIN CORP PLCadr | $0 | – | -150,000 | -100.0% | -0.25% | – |
| Exit | TRANSENTERIX INC | $0 | – | -1,760,262 | -100.0% | -0.26% | – | |
| IWM | Exit | ISHARES RUSSELL 2000etf | $0 | – | -5,900 | -100.0% | -0.28% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS | $0 | – | -1,354,275 | -100.0% | -0.34% | – |
| TTPH | Exit | TETRAPHASE | $0 | – | -667,000 | -100.0% | -0.36% | – |
| BXRX | Exit | BAUDAX BIO INC | $0 | – | -373,977 | -100.0% | -0.38% | – |
| Exit | BARCLAYS IPATHcall | $0 | – | -250 | -100.0% | -0.48% | – | |
| Exit | TRILLIUM THERAPEUTICS | $0 | – | -287,906 | -100.0% | -0.48% | – | |
| OTLK | Exit | OUTLOOK THERAPEUTICS INC | $0 | – | -3,232,342 | -100.0% | -0.81% | – |
| NOVN | Exit | NOVAN INC | $0 | – | -4,438,159 | -100.0% | -0.88% | – |
| GLD | Exit | SPDR GOLD TRUST | $0 | – | -17,934 | -100.0% | -1.10% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -2,166 | -100.0% | -1.15% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.